Search results for: 'Cancer Cell Analysis'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments in female contraception technique, small molecule drugs, cell and gene therapies, cancer diagnosis and treatment and nanobody technologies. The research also encompasses emerging innovations across infectious and immu...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides innovation insights across cell and gene therapy advances. The TOE also encompasses recent therapy developments for neuropsychiatric, rare, and infectious diseases. The research covers recent advances in vaccines and biomanufacturing platforms.The Life ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations cross immunotherapies, precision medicine, cancer treatment, cell engineering, liquid biopsy and AI-enabled drug discovery and development. The TOE also highlights recent advances in implantables, ophthalmology, neurop...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights into recent advancements across small molecules and biologics for cancer treatment. The research also covers innovations for the diagnosis and management of neurological disorders, apart from provide insights for the management of immunological...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights into recent technological developments for molecular marker detection, drug delivery, cancer immunotherapies and radiopharmaceuticals. The TOE also comprises analysis of innovations across cell and gene therapy, antibody and gene editing platfo...

The report describes how predictive biomarkers are changing the global landscape of neuroregeneration and transitioning from the concept of control of brain injury to an active repair of the brain. This report describes how brain injuries from scans were being replaced by blood tests being developed to measure the burden of Alzheimer's disease, mea...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in targeted therapies for cancer, immunological and inflammatory diseases. The research also covers technological developments across vaccines, neuroprotective medicines, cell therapies, monoclonal antibody and oncolytic virus platform...